NCT05252416 2025-11-28(VELA) Study of BLU-222 in Advanced Solid TumorsBlueprint Medicines CorporationPhase 1 Terminated50 enrolled
NCT04681248 2025-08-03Expanded Access Use of DKN-01 for the Treatment of Advanced Solid TumorsLeap Therapeutics, Inc.No longer available
NCT05949632 2025-08-03A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid TumorsIncyte CorporationPhase 1/2 Terminated5 enrolled